← FDA DRUG APPROVALS

FDA ANDA · ANDA214445

BACLOFEN

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA214445
TYPE
ANDA
ORIGINAL APPROVAL
2024-12-06
LATEST ACTION
2025-06-03
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

BACLOFENPrescription
BACLOFEN 5MG/5ML · SOLUTION · ORAL
BACLOFENPrescription
BACLOFEN 10MG/5ML · SOLUTION · ORAL

Approval history

2025-06-03Manufacturing (CMC) · Supplement 2 · unknownAP
2024-12-06UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →